Affinity Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $388K | Sell |
2,048
-51
| -2% | -$9.59K | 0.05% | 77 |
|
|
2026
Q1 | $414K | Sell |
2,099
-1
| -0% | -$193 | 0.06% | 64 |
|
|
2025
Q4 | $386K | Hold |
2,100
| – | – | 0.05% | 69 |
|
|
2025
Q3 | $322K | Buy |
2,100
+51
| +2% | +$7.72K | 0.05% | 77 |
|
|
2025
Q2 | $286K | Hold |
2,049
| – | – | 0.05% | 83 |
|
|
2025
Q1 | $301K | Hold |
2,049
| – | – | 0.06% | 76 |
|
|
2024
Q4 | $268K | Hold |
2,049
| – | – | 0.05% | 85 |
|
|
2024
Q3 | $319K | Sell |
2,049
-3,000
| -59% | -$484K | 0.06% | 81 |
|
|
2024
Q2 | $787K | Hold |
5,049
| – | – | 0.14% | 48 |
|
|
2024
Q1 | $684K | Sell |
5,049
-102
| -2% | -$13.5K | 0.13% | 51 |
|
|
2023
Q4 | $694K | Hold |
5,151
| – | – | 0.14% | 52 |
|
|
2023
Q3 | $698K | Hold |
5,151
| – | – | 0.16% | 54 |
|
|
2023
Q2 | $737K | Buy |
5,151
+102
| +2% | +$15K | 0.17% | 55 |
|
|
2023
Q1 | $701K | Hold |
5,049
| – | – | 0.16% | 58 |
|
|
2022
Q4 | $685K | Hold |
5,049
| – | – | 0.16% | 51 |
|
|
2022
Q3 | $554K | Hold |
5,049
| – | – | 0.14% | 55 |
|
|
2022
Q2 | $677K | Hold |
5,049
| – | – | 0.16% | 53 |
|
|
2022
Q1 | $700K | Hold |
5,049
| – | – | 0.14% | 53 |
|
|
2021
Q4 | $602K | Hold |
5,049
| – | – | 0.12% | 60 |
|
|
2021
Q3 | $608K | Buy |
5,049
+2,049
| +68% | +$239K | 0.12% | 67 |
|
|
2021
Q2 | $347K | Hold |
3,000
| – | – | 0.07% | 71 |
|
|
2021
Q1 | $312K | Hold |
3,000
| – | – | 0.06% | 74 |
|
|
2020
Q4 | $315K | Hold |
3,000
| – | – | 0.07% | 71 |
|
|
2020
Q3 | $321K | Hold |
3,000
| – | – | 0.09% | 59 |
|
|
2020
Q2 | $335K | Hold |
3,000
| – | – | 0.42% | 37 |
|
|
2020
Q1 | $311K | Hold |
3,000
| – | – | 0.19% | 39 |
|
|
2019
Q4 | $299K | Hold |
3,000
| – | – | 0.11% | 73 |
|
|
2019
Q3 | $267K | Hold |
3,000
| – | – | 0.11% | 75 |
|
|
2019
Q2 | $248K | Hold |
3,000
| – | – | 0.1% | 87 |
|
|
2019
Q1 | $243K | Hold |
3,000
| – | – | 0.1% | 90 |
|
|
2018
Q4 | $228K | Buy |
+3,000
| New | +$234K | 0.14% | 86 |
|
|
2017
Q3 | $203K | Hold |
3,000
| – | – | 0.12% | 69 |
|
|
2017
Q2 | $204K | Buy |
+3,000
| New | +$196K | 0.13% | 69 |
|
Other funds holding AZN
EP
IA
Affinity Wealth Management's AZN Position: Q2 2026 in Review
Affinity Wealth Management reduced its AstraZeneca (AZN) stake by 2.4% in Q2 2026, selling an estimated $9.59K and leaving 2,048 shares worth $388K. The position accounts for 0.05% of the portfolio, ranked #77.
Affinity Wealth Management first reported a position in AZN in Q2 2017 and has held it in 33 quarters since. The position peaked at $787K in Q2 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Affinity Wealth Management held 2,048 shares of AstraZeneca worth $388K as of Q2 2026.
- Affinity Wealth Management sold 51 AstraZeneca shares in Q2 2026, an estimated $9.59K.
- AstraZeneca made up 0.05% of Affinity Wealth Management's portfolio in Q2 2026, its #77 holding.
- Affinity Wealth Management first reported a position in AstraZeneca in Q2 2017 and has held it in 33 quarters since.
- Affinity Wealth Management's AstraZeneca position peaked at $787K in Q2 2024.
- 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Affinity Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.